{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T13:25:34Z","timestamp":1768829134588,"version":"3.49.0"},"reference-count":82,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","cell.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Endocrinology & Metabolism"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.tem.2016.02.002","type":"journal-article","created":{"date-parts":[[2016,3,3]],"date-time":"2016-03-03T16:50:36Z","timestamp":1457023836000},"page":"204-215","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":79,"title":["Apolipoprotein L1 and Kidney Disease in African Americans"],"prefix":"10.1016","volume":"27","author":[{"given":"David J.","family":"Friedman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin R.","family":"Pollak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tem.2016.02.002_bib0525","series-title":"US Renal Data System Atlas","year":"2009"},{"key":"10.1016\/j.tem.2016.02.002_bib0530","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1126\/science.1193032","article-title":"Association of trypanolytic ApoL1 variants with kidney disease in African Americans","volume":"329","author":"Genovese","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.tem.2016.02.002_bib0535","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00439-010-0861-0","article-title":"Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene","volume":"128","author":"Tzur","year":"2010","journal-title":"Hum. Genet."},{"key":"10.1016\/j.tem.2016.02.002_bib0540","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1006\/geno.2001.6534","article-title":"The human apolipoprotein L gene cluster: identification, classification, and sites of distribution","volume":"74","author":"Page","year":"2001","journal-title":"Genomics"},{"key":"10.1016\/j.tem.2016.02.002_bib0545","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0022-2275(20)31171-8","article-title":"Apolipoprotein L gene family: tissue-specific expression, splicing, promoter regions; discovery of a new gene","volume":"42","author":"Duchateau","year":"2001","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.tem.2016.02.002_bib0415","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1101\/gr.085647.108","article-title":"The apolipoprotein L family of programmed cell death and immunity genes rapidly evolved in primates at discrete sites of host-pathogen interactions","volume":"19","author":"Smith","year":"2009","journal-title":"Genome Res."},{"key":"10.1016\/j.tem.2016.02.002_bib0550","doi-asserted-by":"crossref","first-page":"1260419","DOI":"10.1126\/science.1260419","article-title":"Proteomics. Tissue-based map of the human proteome","volume":"347","author":"Uhlen","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.tem.2016.02.002_bib0555","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/nature01461","article-title":"Apolipoprotein L-I is the trypanosome lytic factor of human serum","volume":"422","author":"Vanhamme","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.tem.2016.02.002_bib0420","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.1172\/JCI46263","article-title":"Genetics of kidney failure and the evolving story of APOL1","volume":"121","author":"Friedman","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tem.2016.02.002_bib0560","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/nrmicro1428","article-title":"The trypanolytic factor of human serum","volume":"4","author":"Pays","year":"2006","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.tem.2016.02.002_bib0565","doi-asserted-by":"crossref","first-page":"784","DOI":"10.2215\/CJN.08340814","article-title":"Hemostatic factors, APOL1 risk variants, and the risk of ESRD in the Atherosclerosis Risk in Communities Study","volume":"10","author":"Tin","year":"2015","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.tem.2016.02.002_bib0570","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1681\/ASN.2011040388","article-title":"APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy","volume":"22","author":"Kopp","year":"2011","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.tem.2016.02.002_bib0575","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1681\/ASN.2011050519","article-title":"Population-based risk assessment of APOL1 on renal disease","volume":"22","author":"Friedman","year":"2011","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.tem.2016.02.002_bib0580","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/gene.2011.82","article-title":"Role of MYH9 and APOL1 in African and non-African populations with lupus nephritis","volume":"13","author":"Lin","year":"2012","journal-title":"Genes Immun."},{"key":"10.1016\/j.tem.2016.02.002_bib0585","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1681\/ASN.2012121180","article-title":"Apolipoprotein L1 risk variants associate with systemic lupus erythematosus-associated collapsing glomerulopathy","volume":"24","author":"Larsen","year":"2013","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.tem.2016.02.002_bib0590","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/art.38220","article-title":"End-stage renal disease in African Americans with lupus nephritis is associated with APOL1","volume":"66","author":"Freedman","year":"2014","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.tem.2016.02.002_bib0595","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1053\/j.ajkd.2014.02.024","article-title":"Histopathologic effect of APOL1 risk alleles in PLA2R-associated membranous glomerulopathy","volume":"64","author":"Larsen","year":"2014","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.tem.2016.02.002_bib0600","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1056\/NEJMoa1310345","article-title":"APOL1 risk variants, race, and progression of chronic kidney disease","volume":"369","author":"Parsa","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tem.2016.02.002_bib0605","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/ki.2014.255","article-title":"APOL1 associations with nephropathy, atherosclerosis, and all-cause mortality in African Americans with type 2 diabetes","volume":"87","author":"Freedman","year":"2015","journal-title":"Kidney Int."},{"key":"10.1016\/j.tem.2016.02.002_bib0610","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1056\/NEJMoa063265","article-title":"Human Trypanosoma evansi infection linked to a lack of apolipoprotein L-I","volume":"355","author":"Vanhollebeke","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tem.2016.02.002_bib0615","doi-asserted-by":"crossref","first-page":"e51546","DOI":"10.1371\/journal.pone.0051546","article-title":"APOL1 null alleles from a rural village in India do not correlate with glomerulosclerosis","volume":"7","author":"Johnstone","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.tem.2016.02.002_bib0620","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1681\/ASN.2010121234","article-title":"Genetic variation in APOL1 associates with younger age at hemodialysis initiation","volume":"22","author":"Kanji","year":"2011","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.tem.2016.02.002_bib0625","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1093\/ndt\/gfr796","article-title":"APOL1 allelic variants are associated with lower age of dialysis initiation and thereby increased dialysis vintage in African and Hispanic Americans with non-diabetic end-stage kidney disease","volume":"27","author":"Tzur","year":"2012","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.tem.2016.02.002_bib0630","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1681\/ASN.2013070700","article-title":"Plasma apolipoprotein L1 levels do not correlate with CKD","volume":"25","author":"Bruggeman","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.tem.2016.02.002_bib0635","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1194\/jlr.M059733","article-title":"Biogenesis and cytotoxicity of APOL1 renal risk variant proteins in hepatocytes and hepatoma cells","volume":"56","author":"Cheng","year":"2015","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.tem.2016.02.002_bib0640","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1194\/jlr.M063453","article-title":"Characterization of circulating APOL1 protein complexes in African Americans","volume":"57","author":"Weckerle","year":"2016","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.tem.2016.02.002_bib0645","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1681\/ASN.2011010069","article-title":"APOL1 localization in normal kidney and nondiabetic kidney disease","volume":"22","author":"Madhavan","year":"2011","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.tem.2016.02.002_bib0650","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1681\/ASN.2013091017","article-title":"Localization of APOL1 protein and mRNA in the human kidney: nondiseased tissue, primary cells, and immortalized cell lines","volume":"26","author":"Ma","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.tem.2016.02.002_bib0655","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1111\/j.1600-6143.2011.03513.x","article-title":"The APOL1 gene and allograft survival after kidney transplantation","volume":"11","author":"Reeves-Daniel","year":"2011","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.tem.2016.02.002_bib0660","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1111\/ajt.13223","article-title":"Apolipoprotein L1 gene variants in deceased organ donors are associated with renal allograft failure","volume":"15","author":"Freedman","year":"2015","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.tem.2016.02.002_bib0665","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/TP.0000000000000969","article-title":"APOL1 genotype and kidney transplantation outcomes from deceased African American donors","volume":"100","author":"Freedman","year":"2015","journal-title":"Transplantation"},{"key":"10.1016\/j.tem.2016.02.002_bib0670","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1111\/j.1600-6143.2012.04033.x","article-title":"The APOL1 genotype of African American kidney transplant recipients does not impact 5-year allograft survival","volume":"12","author":"Lee","year":"2012","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.tem.2016.02.002_bib0675","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1093\/ndt\/gft423","article-title":"Gene\u2013gene interactions in APOL1-associated nephropathy","volume":"29","author":"Divers","year":"2014","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.tem.2016.02.002_bib0680","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1681\/ASN.2014050469","article-title":"APOL1 risk variants are strongly associated with HIV-associated nephropathy in black South Africans","volume":"26","author":"Kasembeli","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.tem.2016.02.002_bib0685","doi-asserted-by":"crossref","first-page":"607","DOI":"10.2215\/CJN.07311009","article-title":"Treatment with IFN-\u03b1, -\u03b2, or -\u03b3 is associated with collapsing focal segmental glomerulosclerosis","volume":"5","author":"Markowitz","year":"2010","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.tem.2016.02.002_bib0690","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/ki.2014.270","article-title":"Innate immunity pathways regulate the nephropathy gene apolipoprotein L1","volume":"87","author":"Nichols","year":"2015","journal-title":"Kidney Int."},{"key":"10.1016\/j.tem.2016.02.002_bib0695","doi-asserted-by":"crossref","first-page":"214","DOI":"10.7326\/0003-4819-139-3-200308050-00011","article-title":"Pathogenesis and treatment of HIV-associated renal diseases: lessons from clinical and animal studies, molecular pathologic correlations, and genetic investigations","volume":"139","author":"Kimmel","year":"2003","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.tem.2016.02.002_bib0425","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1177\/0961203310371161","article-title":"The interferon-alpha signature of systemic lupus erythematosus","volume":"19","author":"Obermoser","year":"2010","journal-title":"Lupus"},{"key":"10.1016\/j.tem.2016.02.002_bib0700","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1006\/geno.2002.6729","article-title":"The apolipoprotein L gene cluster has emerged recently in evolution and is expressed in human vascular tissue","volume":"79","author":"Monajemi","year":"2002","journal-title":"Genomics"},{"key":"10.1016\/j.tem.2016.02.002_bib0705","doi-asserted-by":"crossref","first-page":"21540","DOI":"10.1074\/jbc.M800214200","article-title":"Apolipoprotein L1, a novel Bcl-2 homology domain 3-only lipid-binding protein, induces autophagic cell death","volume":"283","author":"Wan","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tem.2016.02.002_bib0710","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.4161\/auto.7066","article-title":"ApoL1, a BH3-only lipid-binding protein, induces autophagic cell death","volume":"4","author":"Zhaorigetu","year":"2008","journal-title":"Autophagy"},{"key":"10.1016\/j.tem.2016.02.002_bib0715","doi-asserted-by":"crossref","first-page":"E2130","DOI":"10.1073\/pnas.1400699111","article-title":"Evolution of the primate trypanolytic factor APOL1","volume":"111","author":"Thomson","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.tem.2016.02.002_bib0720","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.yexmp.2015.06.003","article-title":"Protein domains of APOL1 and its risk variants","volume":"99","author":"Lan","year":"2015","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.tem.2016.02.002_bib0725","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.yexmp.2015.03.020","article-title":"Vascular smooth muscle cells contribute to APOL1-induced podocyte injury in HIV milieu","volume":"98","author":"Lan","year":"2015","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.tem.2016.02.002_bib0730","doi-asserted-by":"crossref","first-page":"C22","DOI":"10.1152\/ajpcell.00384.2014","article-title":"Exon 4-encoded sequence is a major determinant of cytotoxicity of apolipoprotein L1","volume":"309","author":"Khatua","year":"2015","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.tem.2016.02.002_bib0735","doi-asserted-by":"crossref","first-page":"F326","DOI":"10.1152\/ajprenal.00647.2013","article-title":"APOL1 risk variants enhance podocyte necrosis through compromising lysosomal membrane permeability","volume":"307","author":"Lan","year":"2014","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.tem.2016.02.002_bib0740","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.molbiopara.2005.08.018","article-title":"Trypanosome lytic factor, a subclass of high-density lipoprotein, forms cation-selective pores in membranes","volume":"144","author":"Molina-Portela Mdel","year":"2005","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.tem.2016.02.002_bib0745","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1126\/science.1114566","article-title":"Apolipoprotein L-I promotes trypanosome lysis by forming pores in lysosomal membranes","volume":"309","author":"Perez-Morga","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.tem.2016.02.002_bib0750","doi-asserted-by":"crossref","first-page":"8078","DOI":"10.1038\/ncomms9078","article-title":"Coupling of lysosomal and mitochondrial membrane permeabilization in trypanolysis by APOL1","volume":"6","author":"Vanwalleghem","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tem.2016.02.002_bib0430","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1073\/pnas.1421953112","article-title":"Human trypanolytic factor APOL1 forms pH-gated cation-selective channels in planar lipid bilayers: relevance to trypanosome lysis","volume":"112","author":"Thomson","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.tem.2016.02.002_bib0755","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1073\/pnas.1522913113","article-title":"APOL1 kidney disease risk variants cause cytotoxicity by depleting cellular potassium and inducing stress-activated protein kinases","volume":"113","author":"Olabisi","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.tem.2016.02.002_bib0760","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nrm3735","article-title":"Self-consumption: the interplay of autophagy and apoptosis","volume":"15","author":"Marino","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.tem.2016.02.002_bib0765","doi-asserted-by":"crossref","first-page":"C332","DOI":"10.1152\/ajpcell.00142.2015","article-title":"BH3 domain-independent apolipoprotein L1 toxicity rescued by BCL2 prosurvival proteins","volume":"309","author":"Heneghan","year":"2015","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.tem.2016.02.002_bib0770","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/ki.2015.109","article-title":"APOL1 toxin, innate immunity, and kidney injury","volume":"88","author":"Limou","year":"2015","journal-title":"Kidney Int."},{"key":"10.1016\/j.tem.2016.02.002_bib0775","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1161\/CIRCRESAHA.114.302347","article-title":"Increased burden of cardiovascular disease in carriers of APOL1 genetic variants","volume":"114","author":"Ito","year":"2014","journal-title":"Circ. Res."},{"key":"10.1016\/j.tem.2016.02.002_bib0780","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1161\/ATVBAHA.115.305970","article-title":"APOL1 genotype, kidney and cardiovascular disease, and death in older adults","volume":"36","author":"Mukamal","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.tem.2016.02.002_bib0785","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/ki.2014.254","article-title":"Apolipoprotein L1 gene variants associate with prevalent kidney but not prevalent cardiovascular disease in the Systolic Blood Pressure Intervention Trial","volume":"87","author":"Langefeld","year":"2015","journal-title":"Kidney Int."},{"key":"10.1016\/j.tem.2016.02.002_bib0790","doi-asserted-by":"crossref","first-page":"748984","DOI":"10.1155\/2012\/748984","article-title":"Variation in APOL1 contributes to ancestry-level differences in HDLc\u2013kidney function association","volume":"2012","author":"Bentley","year":"2012","journal-title":"Int. J. Nephrol."},{"key":"10.1016\/j.tem.2016.02.002_bib0795","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1186\/s12864-015-1645-7","article-title":"APOL1 G1 genotype modifies the association between HDLC and kidney function in African Americans","volume":"16","author":"Bentley","year":"2015","journal-title":"BMC Genomics"},{"key":"10.1016\/j.tem.2016.02.002_bib0800","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1172\/JCI39492","article-title":"Autophagy influences glomerular disease susceptibility and maintains podocyte homeostasis in aging mice","volume":"120","author":"Hartleben","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tem.2016.02.002_bib0805","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1681\/ASN.2012070700","article-title":"Vps34 deficiency reveals the importance of endocytosis for podocyte homeostasis","volume":"24","author":"Bechtel","year":"2013","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.tem.2016.02.002_bib0810","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1128\/IAI.67.4.1910-1916.1999","article-title":"Characterization of a novel trypanosome lytic factor from human serum","volume":"67","author":"Raper","year":"1999","journal-title":"Infect Immun."},{"key":"10.1016\/j.tem.2016.02.002_bib0815","doi-asserted-by":"crossref","first-page":"72","DOI":"10.4161\/viru.3.1.18295","article-title":"Haptoglobin\u2013hemoglobin receptor independent killing of African trypanosomes by human serum and trypanosome lytic factors","volume":"3","author":"Bullard","year":"2012","journal-title":"Virulence"},{"key":"10.1016\/j.tem.2016.02.002_bib0820","doi-asserted-by":"crossref","first-page":"32578","DOI":"10.1074\/jbc.M503510200","article-title":"Human high density lipoproteins are platforms for the assembly of multi-component innate immune complexes","volume":"280","author":"Shiflett","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tem.2016.02.002_bib0435","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1161\/ATVBAHA.109.186031","article-title":"Proteomic analysis of defined HDL subpopulations reveals particle-specific protein clusters: relevance to antioxidative function","volume":"29","author":"Davidson","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.tem.2016.02.002_bib0440","doi-asserted-by":"crossref","first-page":"30254","DOI":"10.1074\/jbc.M010198200","article-title":"Haptoglobin-related protein mediates trypanosome lytic factor binding to trypanosomes","volume":"276","author":"Drain","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tem.2016.02.002_bib0445","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1126\/science.1156296","article-title":"A haptoglobin\u2013hemoglobin receptor conveys innate immunity to Trypanosoma brucei in humans","volume":"320","author":"Vanhollebeke","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.tem.2016.02.002_bib0450","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1128\/EC.05112-11","article-title":"Endosomal localization of the serum resistance-associated protein in African trypanosomes confers human infectivity","volume":"10","author":"Stephens","year":"2011","journal-title":"Eukaryot. Cell"},{"key":"10.1016\/j.tem.2016.02.002_bib0455","first-page":"3063","article-title":"Trypanosome lytic factor-1 initiates oxidation-stimulated osmotic lysis of Trypanosoma brucei brucei","volume":"291","author":"Styer","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tem.2016.02.002_bib0460","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/0035-9203(54)90101-7","article-title":"The distribution of the sickle-cell trait in East Africa and elsewhere, and its apparent relationship to the incidence of subtertian malaria","volume":"48","author":"Allison","year":"1954","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.tem.2016.02.002_bib0465","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/hdy.2011.16","article-title":"Population genetics of malaria resistance in humans","volume":"107","author":"Hedrick","year":"2011","journal-title":"Heredity (Edinb.)"},{"key":"10.1016\/j.tem.2016.02.002_bib0470","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gene.2010.07.008","article-title":"Mechanisms of genetically-based resistance to malaria","volume":"467","author":"Lopez","year":"2010","journal-title":"Gene"},{"key":"10.1016\/j.tem.2016.02.002_bib0475","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S0092-8674(00)81706-7","article-title":"A VSG expression site-associated gene confers resistance to human serum in Trypanosoma rhodesiense","volume":"95","author":"Xong","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.tem.2016.02.002_bib0480","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/nature12516","article-title":"Mechanism of Trypanosoma brucei gambiense resistance to human serum","volume":"501","author":"Uzureau","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.tem.2016.02.002_bib0485","doi-asserted-by":"crossref","first-page":"e1000276","DOI":"10.1371\/journal.ppat.1000276","article-title":"Trypanosome lytic factor, an antimicrobial high-density lipoprotein, ameliorates Leishmania infection","volume":"5","author":"Samanovic","year":"2009","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.tem.2016.02.002_bib0490","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1128\/JVI.02828-13","article-title":"The innate immune factor apolipoprotein L1 restricts HIV-1 infection","volume":"88","author":"Taylor","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.tem.2016.02.002_bib0495","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12977-015-0165-5","article-title":"Identification of potential HIV restriction factors by combining evolutionary genomic signatures with functional analyses","volume":"12","author":"McLaren","year":"2015","journal-title":"Retrovirology"},{"key":"10.1016\/j.tem.2016.02.002_bib0500","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/S0272-6386(00)70055-2","article-title":"Parvovirus B19 DNA in kidney tissue of patients with focal segmental glomerulosclerosis","volume":"35","author":"Tanawattanacharoen","year":"2000","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.tem.2016.02.002_bib0505","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1046\/j.1523-1755.2001.00727.x","article-title":"Association of parvovirus B19 infection with idiopathic collapsing glomerulopathy","volume":"59","author":"Moudgil","year":"2001","journal-title":"Kidney Int."},{"key":"10.1016\/j.tem.2016.02.002_bib0510","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1038\/ki.2013.173","article-title":"JC polyoma virus interacts with APOL1 in African Americans with nondiabetic nephropathy","volume":"84","author":"Divers","year":"2013","journal-title":"Kidney Int."},{"key":"10.1016\/j.tem.2016.02.002_bib0515","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000353223","article-title":"High population frequencies of APOL1 risk variants are associated with increased prevalence of non-diabetic chronic kidney disease in the Igbo people from south-eastern Nigeria","volume":"123","author":"Ulasi","year":"2013","journal-title":"Nephron Clin. Pract."},{"key":"10.1016\/j.tem.2016.02.002_bib0520","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1681\/ASN.2013010113","article-title":"APOL1 variants associate with increased risk of CKD among African Americans","volume":"24","author":"Foster","year":"2013","journal-title":"J. Am. Soc. Nephrol."}],"container-title":["Trends in Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043276016000199?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043276016000199?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,6]],"date-time":"2022-06-06T15:19:20Z","timestamp":1654528760000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043276016000199"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":82,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["S1043276016000199"],"URL":"https:\/\/doi.org\/10.1016\/j.tem.2016.02.002","relation":{},"ISSN":["1043-2760"],"issn-type":[{"value":"1043-2760","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Apolipoprotein L1 and Kidney Disease in African Americans","name":"articletitle","label":"Article Title"},{"value":"Trends in Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tem.2016.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}